BIOREGENX, INC. (BRGX) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$1.9M

Net Income/Loss (FY2025)

-$1.5M

Total Assets (FY2025)

$411.0K

Total Equity (FY2025)

-$4.5M

Cash Flows from Operating Activities (FY2025)

$39.0K

Source: BIOREGENX, INC. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.